• June 2012 - Actinium Pharmaceuticals Treats First Patients in Multicenter Phase 1/2 Leukemia Trial of Actimab-A™
    ( download file)

  • December 2011 - Actinium Pharmaceuticals Announces Presentation of Interim Results from MSKCC Phase 1 AML Trial at the American Society of Hematology Meeting ( download file)

  • October 2011 - Actinium Pharmaceuticals Raises $4.1 Million in Initial Closing of Series E Financing
    ( download file)

  • September 2005 – Novel antibodies discovered by GSF licensed to Actinium Pharmaceuticals for the development of targeted gastric cancer treatment ( download file )

  • March 2003 – Protein Design Labs Licenses Development Rights to SMART(™) M 195 Antibody To Actinium Pharmaceuticals (download file )

  • January 2003 – Actinium Pharmaceuticals and Department of Energy's Pacific Northwest National Laboratory Announce Collaboration to Support Development of a Novel Cancer Treatment ( download file)

  • November 2002 – Actinium Developing Novel Anticancers (download file )

  • September 2002 – Actinium Pharmaceuticals announces Collaboration with Memorial Sloan Kettering Cancer Center for a Novel Targeted Cancer Immunotherapy (download file )